NM_032043.3:c.1474-18T>C

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_032043.3(BRIP1):c.1474-18T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene BRIP1 is a tumor suppressor gene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The gene BRIP1 is a known oncogene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The gene BRIP1 is a cancer driver gene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

BRIP1
NM_032043.3 intron

Scores

3

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.42

Publications

0 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting DNA helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032043.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_032043.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRIP1 NM_032043.3
MANE Select
HGVSc / HGVSpc.1474-18T>C
Exon rankIntron 10 of 19
intron
Prot: NP_114432.2UniProt: Q9BX63-1

Ensembl Transcripts

BRIP1 ENST00000259008.7
TSL:1MANE Select
HGVSc / HGVSpc.1474-18T>C
Exon rankIntron 10 of 19
intron
Prot: ENSP00000259008.2UniProt: Q9BX63-1
BRIP1 ENST00000682453.1
HGVSc / HGVSpc.1474-18T>C
Exon rankIntron 11 of 20
intron
Prot: ENSP00000506943.1UniProt: Q9BX63-1
BRIP1 ENST00000683039.1
HGVSc / HGVSpc.1474-18T>C
Exon rankIntron 11 of 20
intron
Prot: ENSP00000508303.1UniProt: Q9BX63-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Familial cancer of breast (1)
-
-
1
Familial cancer of breast;C1836860:Fanconi anemia complementation group J (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)

Computational Scores

AlphaGenome AVI
Uncertain13
BayesDel_noAF
Benign-0.81
CADD
Benign16
DANN
Benign0.73
GPN-Star LLR
N/A-2.7
GPN-Star score
N/A2.7
PhyloP100
Benign2.4
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.